SAN DIEGO, Feb. 02, 2018 -- After Tuesday’s State of the Union Address, The Recover examines Trump’s message to lower prescription costs and fight for the dying rights of those with terminal conditions.
|
|||||
In his speech he addressed the “Right to Try” Legislation that was proposed but is waiting on approval from the FDA. "We also believe that patients with terminal conditions should have access to experimental treatments that could potentially save their lives," the president said.
"People who are terminally ill should not have to go from country to country to seek a cure — I want to give them a chance right here at home. It is time for the Congress to give these wonderful Americans the 'right to try,'" he says.
The prescription drug cost has been rising in recent years, with medications dramatically increasing 44% since 2003, and continues to grow with out interference. Trump proposes to prevent that from happening under his administration, but without a clear plan.
"One of my greatest priorities is to reduce the price of prescription drugs. In many other countries, these drugs cost far less than what we pay in the United States," Trump stated.
"And it is very, very unfair," he said. "That is why I have directed my administration to make fixing the injustice of high drug prices one of our top priorities. Prices will come down."
The President will also have to address the issue that some of these prescription drugs have led to the opioid problem the country faces. Other pain relievers and stimulant prescription drugs can be misused and can cause an addiction to the user.
Alex Azar was in attendance at the address, a former drug company executive, lobbyist and spokesperson who has been sworn in as Secretary of Health and Human Services under President Trump's cabinet. Mr. Azar’s former profession brings into question how someone from that industry could possibly have a hand in disrupting their profit and helping the people of America. While introducing Azar, Trump mentioned several times that he shared his desire in reducing prescription drug prices.
Author: Kevin Leonard
Organization: TheRecover.com
Address: 27420 Jefferson Ave 101a, Temecula, CA 92590
Phone: 888-510-3898
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/cf3a285e-8af4-4ac2-89ce-40e8b07cda15


Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Instagram Outage Disrupts Thousands of U.S. Users
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 



